|
Basic Characteristics of Mutations
|
|
Mutation Site
|
P142S |
|
Mutation Site Sentence
|
One child had a double mutation (P142S and G145R) and the other a G145A substitution. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
S |
|
Standardized Encoding Gene
|
S
|
|
Genotype/Subtype
|
B;C |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Liver Diseases
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
- |
|
Location
|
China |
|
Literature Information
|
|
PMID
|
11264736
|
|
Title
|
Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient
|
|
Author
|
Seddigh-Tonekaboni S,Lim WL,Young B,Hou JL,Waters J,Luo KX,Thomas HC,Karayiannis P
|
|
Journal
|
Journal of viral hepatitis
|
|
Journal Info
|
2001 Mar;8(2):154-8
|
|
Abstract
|
Variants of hepatitis B virus (HBV), with amino acid substitutions in the major antigenic ""a"" determinant of hepatitis B surface antigen (HBsAg), have been described mainly in vaccinated children. In the present study in addition to vaccinated children, we have investigated Chinese blood donors positive for anti-HBc alone, and a patient with continuing liver disease after interferon-induced seroconversion to anti-HBs. Variants were detected in two of four children with break-through infections. One child had a double mutation (P142S and G145R) and the other a G145A substitution. Three of seven anti-HBc positive Chinese blood donors had a T131I substitution, whilst the interferon-treated patient had a treble amino acid substitution (P142S, G145R and N146D). The present results indicate that HBsAg variants may exist in individuals other than vaccinated children.
|
|
Sequence Data
|
-
|